Virtus Biotech Clinical TriaBBCETF
13F holders, Q1 2024 (March 31)17holders
$29.12avg. 13F price*
At the end of Q1 2024, 17 institutions reported holding Virtus Biotech Clinical Tria (BBC) in their 13F filings. The largest holders were Morgan Stanley ($1.2M), LPL Financial LLC ($420K) and Susquehanna International Group, LLP ($360K).
- Company
- Virtus Biotech Clinical Tria
- Filed as
- ETFIS SER TR I (Q1 2024)
- CUSIP
- 26923G301
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $9K |
| Exits | 3 | $935K |
Ownership 17 holders
| Morgan Stanley | 0.00% | Add +342.2% | 40,290 | $1.2M |
| LPL Financial LLC | 0.00% | Reduce -1.4% | 14,404 | $420K |
| Susquehanna International Group, LLP | 0.00% | Reduce -74.2% | 12,367 | $360K |
| US Bancorp \de | 0.00% | No change | 1,000 | $29K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 838 | $24K |
| Dynamic Wealth Strategies, LLC | 0.02% | No change | 802 | $23K |
| Duncker Streett & Co. Inc. | 0.00% | No change | 752 | $22K |
| UBS Group AG | 0.00% | Reduce -51.8% | 698 | $20K |
| Osaic Holdings, Inc. | 0.00% | No change | 447 | $13K |
| Harbour Investments, Inc. | 0.00% | Reduce -28.9% | 310 | $9K |
| Comerica Bank | 0.00% | New | 283 | $8K |
| Baldwin Wealth Partners LLC | 0.00% | No change | 100 | $3K |
| DecisionPoint Financial, LLC | 0.00% | No change | 62 | $2K |
| Global Retirement Partners, LLC | 0.00% | Reduce -82.0% | 44 | $1K |
| FMR LLC | 0.00% | New | 12 | $350 |
| Allworth Financial LP | 0.00% | No change | 10 | $292 |
| NewEdge Advisors, LLC | 0.00% | No change | 5 | $146 |
"% of holder's portfolio" is BBC's weight in each manager's 13F, not the share of Virtus Biotech Clinical Tria the manager owns.